FDA.reportPublic FDA data

Jynarque 30 MG Oral Tablet

RxCUI
2044357
RxNorm name
Jynarque 30 MG Oral Tablet
Display name
Jynarque 30 MG Oral Tablet
Full name
Jynarque 30 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:55

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3febc0a1-9e5a-4ce0-843d-210f21d862c4JYNARQUE 30 MG Oral Tablet [PSN] · tolvaptan 30 MG Oral Tablet [Jynarque] [SBD] · Jynarque 30 MG Oral Tablet [SY]319These highlights do not include all the information needed to use JYNARQUE safely and effectively. See full prescribing information for JYNARQUE. JYNARQUE ® (tolvaptan) tablets, for oral use Initial U.S. Approval: 200920251106